Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
IntroductionIntroduction
Oral bacteria are major causative agents of pulpal and peri-
apical diseases. The treatment of these is performed through
dental root canal enlargement, cleansing, and disinfection and
the main purpose of root canal therapy is to remove bacteria
present in the root canal and to prevent reinfection [1-3]. The
persistent or secondary infection of the root canal is the main
cause of root canal treatment failure. Staphylococcus aureus
and Enterococcus faecalis are the pathogenic bacteria of en-
dondontic infection [4]. S. aureus is a representative purulent
bacterial species and is also isolated from endodontic infection
lesions, so it has been used as a target bacterium for evalua-
tion of antimicrobial property of dental materials used for vari-
ous root canal treatments [5,6]. E. faecalis has been reported
as a major causative agent of root canal failure [7,8].
Recently, chlorhexidine or Mixture of Tetracycline, an Acid,
and a Detergent (MTAD) has been used as antimicrobial agent
mixed with root canal sealer for root canal treatment [3,9].
However, chlorhexidine has toxicity to oral tissue cells and
Int J Oral Biol 46:45-50, 2021pISSN: 1226-7155 • eISSN: 2287-6618https://doi.org/10.11620/IJOB.2021.46.1.45
The antibacterial effect of Endoseal TCS mixed with water-soluble mangostin derivatives of Garcinia mangostana L. ethanol extract against Enterococcus faecalis and Staphylococcus aureusTae-Young Park1†, Yun Kyong Lim2,3†, Jin-Hee Kim3,4, Dae Sung Lee4*, and Joong-Ki Kook2,3*
1Department of Conservative Dentistry, Chosun University, Gwangju 61452, Republic of Korea 2Korean Collection for Oral Microbiology, Chosun University, Gwangju 61452, Republic of Korea 3Department of Oral Biochemistry, School of Dentistry, Chosun University, Gwangju 61452, Republic of Korea 4Medi Bio Lab Co., Ltd., Seoul 61452, Republic of Korea
This study evaluated the antimicrobial activity of Endoseal TCS, an mineral trioxide aggregate-based root canal sealer, mixed with water-soluble mangostin derivatives (WsMD) of Garcinia mangostana L. (mangosteen) ethanol extract against Enterococcus faecalis and Staphylococcus aureus. The antibacterial activity of Endoseal TCS mixed with WsMD against three strains of E. faecalis and three strains of S. aureus was performed using agar diffusion test. The data showed that Endoseal TCS mixed with 0.115% WsMD had a zone of inhibition of 0.7 ± 0.2–2.4 ± 0.1 mm. The results suggest that Endoseal TCS mixed with WsMD of Garcinia mangostana L. ethanol extract is useful as a root canal sealer with antibacterial activity against E. faecalis and S. aureus.
Keywords: Endoseal TCS, Garcinia mangostana L., Enterococcus faecalis, Staphylococcus aureus, Antibacterial effect
Received January 25, 2021; Accepted March 19, 2021*Correspondence to: Joong-Ki Kook, E-mail: [email protected] https://orcid.org/0000-0003-2628-2870*Correspondence to: Dae Sung Lee, E-mail: [email protected] https://orcid.org/0000-0003-2317-7848†Tae-Young Park and Yun Kyong Lim contributed equally to this work.
Copyright © The Korean Academy of Oral BiologyCC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original Article IJOBInternational Journal of Oral Biology
Int J Oral Biol Vol. 46, No. 1, March 2021
46 www.kijob.or.kr
MTAD has possibility of inducing new tetracycline-resistant
bacteria or has not effect tetracycline-sensitive bacteria that
are existed in root canal [10,11]. Therefore, they are used as
root canal cleaners rather than as sealers for root canals [10,12].
Therefore, studies are being conducted to find an antimicrobial
substance derived from natural products that can be used in
combination with an endodontic treatment material to over-
come these problems [13]. The previous study, the ethanol
extract of Garcinia mangostana L. (magosteen) had strong an-
timicrobial activity against S. aureus and E. faecalis [14,15].
Since mineral trioxide aggregate (MTA) was introduced by
Torabinejad and Chivian [16], it has been widely used in the
field of endodontic treatment. Recently, MTA-based root seal-
er has been developed and delivered via a syringe. This sealer
was reported to have better biocompatibility than conventional
resin sealers for root canal filling [17]. However, it was reported
that the antimicrobial effect of MTA was very low [18]. There-
fore, in this study, the antimicrobial activity of Endoseal TCS®
(MARUCHI Co., Ltd., Wonju, Korea), an MTA-based root canal
sealer, mixed with the water-soluble mangostin derivatives
(WsMD) of the ethanol extract of magosteen against E. faeca-
lis and S. aureus was evaluated.
Materials and MethodsMaterials and Methods
1. Bacteria and bacterial culture
The E. faecalis (KCOM 1083, KCOM 1161, KCOM 2823) and
S. aureus (KCOM 1335, KCOM 1395, KCOM 1491) strains used
in this study were obtained from the Korean Collection for
Oral Microbiology (Gwangju, Korea). These strains were grown
on brain heart infusion (BHI, BD Difco Laboratories, Franklin
Lakes, NJ, USA) broth or BHI agar medium in an incubator at
37℃ for 24 hours.
2. Preparation of water-soluble mangostin derivative
powder
Mangosteen ethanol extract was purchased from Maypro
Industries® (Purchase, NY, USA). To impart water solubility to
the mangosteen ethanol extract, a certain amount of mango-
steen ethanol extract powder was added to purified water and
stirred at 50℃ and 1 atmosphere (atm) for 1 hour. Thereafter,
L-arginine was added to the solution and stirred at 50℃ and
1 atm for 1 hour. The pH at this time was maintained at 9–10.
L-arginine (1%, w/w) and KOH, an alkaline metal salt used as
a catalyst, were added to the solution and stirred at 70℃ and
1 atm for 2 hours to form WsMD. The pH was maintained at
9–10. After the color of the solution changed from ocher to
black, it was cooled to 4℃ and left at room temperature for 12
hours to increase the stability of the WsMD. The solution was
vacuum-dried at 0.4 atm and 60℃ to prepare WsMD powder
(Fig. 1).
3. Preparation of mixed sample of WsMD powder and
Endoseal TCS®
Endoseal TCS® was mixed with a WsMD at weight propor-
tions of 0.023%, 0.07%, or 0.115% to prepare premixed inject-
able pastes. These were provided by MARUCHI Co., Ltd.
4. Antibacterial test
Agar diffusion tests were performed by a modification of the
method of Hasheminia et al. [19]. Briefly, 10 mL of the steril-
ized BHI agar medium was poured into a sterilized 90-mm
Petri dish and then a paper disk (8 × 0.5 mm) was placed into
the agar medium. The bacterial strain was grown in BHI broth
at 37℃ for 16 hours in an incubator. It was diluted to 106 CFU/
mL with BHI agar solution cooled to 40℃ and then 10 mL was
poured onto the previously solidified BHI agar medium. After
Mangostin
L-arginine
KOH
Stirred at 50
in pH 9 10for 1 hr
Stirred at 70
in pH 9 10for 2 hr
Cool to 40
and left at 25
for 2 hrVacuum-driedat 0.4 atm and
60
OHHO
OCH3
O
CH =CHCH2
CH3OH O CH CH=CCH2 3
CH3
3C
OHHO
OCH3
O
CH =CHCH2
CH3OH O CH CH=CCH2 3
CH3
3C
+NH
C = NH
NH
(CH )
CHNH
COOH
2
2 3
2
NH
C = NH
NH
(CH )
CHNH
COOH
2
2 3
2
NH
C = NH
NH
(CH )
CHNH
COOH
2
2 3
2
Fig. 1. Schematic diagram for preparing water-soluble mangostin derivatives from the ethanol extract of mangosteen.
Tae-Young Park, et al. Antimicrobial effect of Endoseal TCS and mangosteen
www.kijob.or.kr 47
the BHI agar solution mixed with the bacterial strain was so-
lidified, the paper disc was carefully removed. Two mL of En-
doseal TCS® (control), or Endoseal TCS® mixed with 0.023% (w/
w), 0.07% (w/w), or 0.115% (w/w) of WsMD by injecting us-
ing a syringe with a 24G needle. The plates were incubated for
24 hours in an incubator at 37℃ and the zone of inhibition was
measured. The length from the edge of the Endoseal TCS® to
the edge of the inhibition zone was measured and recorded.
This experiment was repeated three times and the antibacte-
rial activity is presented as the mean ± standard error of the
length of the zone of inhibition.
Results Results
The antimicrobial activity of the WsMD mixed with Endoseal
TCS® against E. faecalis and S. aureus strains was evaluated
by agar diffusion tests. The data showed that Endoseal TCS®
mixed with 0.115% WsMD created a zone of inhibition that
ranged from 0.7 ± 0.2 to 2.4 ± 0.1 mm (Fig. 2 and Table 1).
Among the strains used in this study, E. faecalis KCOM 2823
was more resistant to Endoseal TCS® containing the most
WsMD compared to the other strains (Fig. 2 and Table 1). In
contrast, the S. aureus KCOM 1491 strain was the most sus-
ceptible (Fig. 2 and Table 1). In the case of Endoseal TCS®,
which was used as a control, antibacterial activity was not ob-
served (Fig. 2 and Table 1).
DiscussionDiscussion
In this study, WsMD were mixed with Endoseal TCS®, an
MTA-based root canal sealer, to impart antibacterial properties,
which were investigated by agar diffusion tests. The zone of
inhibition was increased by adding higher amounts of WsMD
(Fig. 1 and Table 1). According to previous studies, the mini-
mum bactericidal concentration (MBC) values of the ethanol
extract of mangosteen containing about 40% alpha-mangostin
against E. faecalis (KCOM 1083, KCOM 1161, KCOM 2823) and
S. aureus (KCOM 1335, KCOM 1395, KCOM 1491) were be-
tween 2 and 8 µg/mL [14,15]. To investigate the antimicrobial
activity of the WsMD compared to the mangosteen ethanol
extract, the MBC value of WsMD against S. aureus KCOM
1491 was measured. The MBC value of WsMD against S. au-
1122
33 44
A B C
D E F
1122
33 44
1122
33 44
1122
33 44
1122
33 44
1122
33 44
Fig. 2. Agar diffusion test. The zones of inhibition against (A) Enterococcus faecalis KCOM 1083, (B) E. faecalis KCOM 1161, (C) E. faecalis KCOM 2823, (D) Staphylococcus aureus KCOM 1335, (E) S. aureus KCOM 1395, and (F) S. aureus KCOM 1491 were increased depending upon the amount of water-soluble mangostin derivatives (WsMD) from the etha-nol extract of mangosteen added to Endoseal TCS®. 1, Endoseal TCS® (control); 2, Endoseal TCS® + 0.023% WsMD from the ethanol extract of mangosteen; 3, Endoseal TCS® + 0.07% WsMD from the ethanol extract of mangosteen; 4, Endoseal TCS® + 0.115% WsMD from the ethanol extract of mangosteen.
Table 1. Antimicrobial activity of mineral trioxide aggregate-based root canal sealer (Endoseal TCS®) with water-soluble mangostin derivatives from the ethanol extract of mangosteen against Enterococcus faecalis and Staphylococcus aureus
Species and strains
Zone of inhibition (mm)
Control (Endoseal TCS®)Endoseal TCS® + 0.023%
mangostin derivativesa Endoseal TCS® + 0.07%
mangostin derivatives Endoseal TCS® + 0.115%
mangostin derivatives
E. faecalis KCOM 1083 0 0 0.7 ± 0.2 1.6 ± 0.2
E. faecalis KCOM 1161 0 0 0.4 ± 0.1 0.9 ± 0.2
E. faecalis KCOM 2823 0 0 0 0.7 ± 0.2
S. aureus KCOM 1335 0 0 0.6 ± 0.3 1.5 ± 0.1
S. aureus KCOM 1395 0 0 0.8 ± 0.1 1.4 ± 0.2
S. aureus KCOM 1491 0 0.7 ± 0.1 2.0 ± 0.1 2.4 ± 0.1
Values are presented as mean ± standard deviation.aWater-soluble mangostin derivatives from the ethanol extract of mangosteen.
Int J Oral Biol Vol. 46, No. 1, March 2021
48 www.kijob.or.kr
reus KCOM 1491 was the same, 2 µg/mL, as that of mango-
steen ethanol extract (data not shown). These results indicate
that the antimicrobial activity of the WsMD was maintained
and might be released when mixed with Endoseal TCS®. How-
ever, further study is needed to investigate how the WsMD
were produced and released from the Endoseal TCS® mixture.
Little antimicrobial activity of MTA Fillapex, another MTA-
based root canal sealer developed in Brazil, against E. faecalis
was seen in the agar diffusion tests in previous studies [18,19].
However, the antimicrobial activity of MTA Fillapex that was
cured and pulverized against E. faecalis was excellent [19]. The
antimicrobial mechanisms of MTA are explained in two ways.
The first is that MTA produces reactive oxygen species in the
atmosphere, with antibacterial effects [20]. Second, MTA con-
tains calcium oxide. Therefore, when it comes into contact
with water, calcium hydroxide is formed, which increases the
pH and exhibits an antibacterial effect [21-23]. It is known that
E. faecalis cannot survive at a pH of 11.5 or higher. Therefore,
water is essential for MTA to have an antibacterial effect on
E. faecalis. This means that the MTA-based root canal sealer
loses its antimicrobial activity after curing. Thus, the addition of
a water-soluble antibacterial agent is considered necessary to
impart antibacterial activity to the MTA-based root canal sealer,
as in this study.
As a result of studies comparing the antimicrobial activity of
various types of root canal sealer currently in use, the antibac-
terial effect of the MTA-based sealer against E. faecalis was
lower than that of the other types of root canal sealers [18,24-
26]. When using only MTA, the antibacterial effect was lower
than that of the conventional sealer. Therefore, there have
been attempts to increase the antibacterial effect by adding
chlorhexidine to MTA [9,27]. However, when chlorhexidine was
added, the antibacterial effect was increased, but the physical
properties of the MTA itself were deteriorated [9]. Based on
these results, we intend to conduct future studies on whether
Endoseal TCS® containing the WsMD used in this study has
clinically usable properties.
Another study on the antimicrobial effect of MTA-based
sealers against E. faecalis showed some antimicrobial effects
of MTA Fillapex and Endofill against E. faecalis but did not dis-
play complete inhibition and the high pH of the MTA-based
sealer was increased after seven days [28]. In this study, the
Endoseal TCS® component spread to the inhibitory zone from
the second day and began to become opaque, and from the
third day, the agar medium dried, making it difficult to identify
the antibacterial activity (data not shown). Therefore, animal
experiments will be used to evaluate the duration of the an-
timicrobial activity of Endoseal TCS® containing WsMD in the
future.
According to the above results, the higher the content of
WsMD mixed with Endoseal TCS®, the higher the antibacterial
effect. With more than 0.115% WsMD mixed with Endoseal
TCS®, the color tone of the sealer changed and the flowability
was impaired, resulting in the loss of function as a sealer for
root canal filling. Therefore, the proper concentration of WsMD
for mixing with Endoseal TCS® was 0.115%.
In summary, Endoseal TCS® mixed with the WsMD of the
ethanol extract of Magosteen might be useful as a root canal
sealer with antibacterial activity against E. faecalis and S. au-
reus.
AcknowledgementsAcknowledgements
We thank CEO Sung-Wook of MARUCHI Co., Ltd. for mak-
ing a pre-mixed injectable paste containing the mixture of En-
doseal TCS® and WsMD.
Conflicts of InterestConflicts of Interest
Dae Sung Lee and Jin-Hee Kim are co-applicants on patent
application 10-2020-0152138 entitled “Composition for filling
root canal comprising mangosteen extract.” The other authors
have no conflicts of interest to declare.
ReferencesReferences
1. Haapasalo M, Endal U, Zandi H, Coil JM. Eradication of end-
odontic infection by instrumentation and irrigation solutions.
Endod Topics 2005;10:77-102. doi: 10.1111/j.1601-1546.
2005.00135.x.
2. Molander A, Reit C, Dahlén G, Kvist T. Microbiological sta-
tus of root-filled teeth with apical periodontitis. Int Endod J
1998;31:1-7.
3. Sharaf NF, Alshareef WA. The comparative evaluation of the
post-antimicrobial effect of MTAD® and 2% chlorhexidine
against Enterococcus faecalis of permanent teeth with ne-
crotic pulp. Open Access Maced J Med Sci 2019;7:3270-5.
doi: 10.3889/oamjms.2019.570.
Tae-Young Park, et al. Antimicrobial effect of Endoseal TCS and mangosteen
www.kijob.or.kr 49
4. Siqueira JF Jr, Rôças IN. Clinical implications and microbiology
of bacterial persistence after treatment procedures. J Endod
2008;34:1291-301.e3. doi: 10.1016/j.joen.2008.07.028.
5. ElReash AA, Hamama H, Eldars W, Lingwei G, Zaen El-Din
AM, Xiaoli X. Antimicrobial activity and pH measurement of
calcium silicate cements versus new bioactive resin compos-
ite restorative material. BMC Oral Health 2019;19:235. doi:
10.1186/s12903-019-0933-z.
6. Özyürek T, Demiryürek EÖ. Comparison of the antimicrobial
activity of direct pulp-capping materials: mineral trioxide
aggregate-Angelus and Biodentine. J Conserv Dent 2016;19:
569-72. doi: 10.4103/0972-0707.194018.
7. Siqueira JF Jr, Rôças IN. Polymerase chain reaction-based
analysis of microorganisms associated with failed endodontic
treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2004;97:85-94. doi: 10.1016/s1079-2104(03)00353-6.
8. Zoletti GO, Siqueira JF Jr, Santos KR. Identification of Entero-
coccus faecalis in root-filled teeth with or without periradicular
lesions by culture-dependent and-independent approaches.
J Endod 2006;32:722-6. doi: 10.1016/j.joen.2006.02.001.
9. Holt DM, Watts JD, Beeson TJ, Kirkpatrick TC, Rutledge RE.
The anti-microbial effect against enterococcus faecalis and
the compressive strength of two types of mineral trioxide ag-
gregate mixed with sterile water or 2% chlorhexidine liquid. J
Endod 2007;33:844-7. doi: 10.1016/j.joen.2007.04.006.
10. Eley BM. Antibacterial agents in the control of supragingival
plaque--a review. Br Dent J 1999;186:286-96. doi: 10.1038/
sj.bdj.4800090.
11. O’Connor BC, Newman HN, Wilson M. Susceptibility and
resistance of plaque bacteria to minocycline. J Periodontol
1990;61:228-33. doi: 10.1902/jop.1990.61.4.228.
12. Naik MM, de Ataide Ide N, Fernandes M, Lambor R. Assess-
ment of apical seal obtained after irrigation of root end cavity
with MTAD followed by subsequent retrofilling with MTA and
Biodentine: an in vitro study. J Conserv Dent 2015;18:132-5.
doi: 10.4103/0972-0707.153068.
13. Cavenago BC, Del Carpio-Perochena AE, Ordinola-Zapata R,
Estrela C, Garlet GP, Tanomaru-Filho M, Weckwerth PH, de
Andrade FB, Duarte MAH. Effect of using different vehicles on
the physicochemical, antimicrobial, and biological properties
of white mineral trioxide aggregate. J Endod 2017;43:779-86.
doi: 10.1016/j.joen.2016.12.023.
14. Park TY, Lim YK, Lee DS, Kook JK. Antimicrobial effect of
ethanol extract of Garcinia mangostana L. against Enterococ-
cus faecalis Isolated from human oral cavity. Int J Oral Biol
2018;43:129-32. doi: 10.11620/IJOB.2018.43.3.129.
15. Lim YK, Yoo SY, Park SN, Lee DS, Kook JK. Antimicrobial
activity of Garcinia mangostana L. ethanol extract against Cu-
tibacterium acnes and Staphylococcus aureus. Int J Oral Biol
2019;44:101-7. doi: 10.11620/IJOB.2019.44.3.101.
16. Torabinejad M, Chivian N. Clinical applications of mineral tri-
oxide aggregate. J Endod 1999;25:197-205. doi: 10.1016/
S0099-2399(99)80142-3.
17. Bin CV, Valera MC, Camargo SE, Rabelo SB, Silva GO, Bal-
ducci I, Camargo CH. Cytotoxicity and genotoxicity of root
canal sealers based on mineral trioxide aggregate. J Endod
2012;38:495-500. doi: 10.1016/j.joen.2011.11.003.
18. Dalmia S, Gaikwad A, Samuel R, Aher G, Gulve M, Kolhe S.
Antimicrobial efficacy of different endodontic sealers against
Enterococcus faecalis: an in vitro Study. J Int Soc Prev Com-
munity Dent 2018;8:104-9. doi: 10.4103/jispcd.JISPCD_29_
18.
19. Hasheminia M, Razavian H, Mosleh H, Shakerian B. In vitro
evaluation of the antibacterial activity of five sealers used in
root canal therapy. Dent Res J (Isfahan) 2017;14:62-7. doi:
10.4103/1735-3327.201141.
20. Ribeiro CS, Scelza MF, Hirata Júnior R, Buarque de Oliveira
LM. The antimicrobial activity of gray-colored mineral trioxide
aggregate (GMTA) and white-colored MTA (WMTA) under
aerobic and anaerobic conditions. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod 2010;109:e109-12. doi: 10.1016/j.
tripleo.2010.02.008.
21. Zhang H, Pappen FG, Haapasalo M. Dentin enhances the anti-
bacterial effect of mineral trioxide aggregate and bioaggregate.
J Endod 2009;35:221-4. doi: 10.1016/j.joen.2008.11.001.
22. Torabinejad M, Hong CU, McDonald F, Pitt Ford TR. Physi-
cal and chemical properties of a new root-end filling mate-
rial. J Endod 1995;21:349-53. doi: 10.1016/S0099-2399(06)
80967-2.
23. Al-Hezaimi K, Al-Shalan TA, Naghshbandi J, Oglesby S, Si-
mon JH, Rotstein I. Antibacterial effect of two mineral trioxide
aggregate (MTA) preparations against Enterococcus faecalis
and Streptococcus sanguis in vitro. J Endod 2006;32:1053-6.
doi: 10.1016/j.joen.2006.06.004.
24. Miyagak DC, de Carvalho EM, Robazza CR, Chavasco JK,
Levorato GL. In vitro evaluation of the antimicrobial activity of
endodontic sealers. Braz Oral Res 2006;20:303-6. doi: 10.
1590/s1806-83242006000400004.
25. Estrela C, Bammann LL, Estrela CR, Silva RS, Pécora JD. An-
timicrobial and chemical study of MTA, Portland cement, cal-
cium hydroxide paste, Sealapex and Dycal. Braz Dent J 2000;
11:3-9.
Int J Oral Biol Vol. 46, No. 1, March 2021
50 www.kijob.or.kr
26. Tanomaru-Filho M, Tanomaru JM, Barros DB, Watanabe E, Ito
IY. In vitro antimicrobial activity of endodontic sealers, MTA-
based cements and Portland cement. J Oral Sci 2007;49:41-
5. doi: 10.2334/josnusd.49.41.
27. Mittag SG, Eissner C, Zabel L, Wrbas KT, Kielbassa AM. The
influence of chlorhexidine on the antibacterial effects of MTA.
Quintessence Int 2012;43:901-6.
28. Morgental RD, Vier-Pelisser FV, Oliveira SD, Antunes FC,
Cogo DM, Kopper PM. Antibacterial activity of two MTA-
based root canal sealers. Int Endod J 2011;44:1128-33. doi:
10.1111/j.1365-2591.2011.01931.x.